Clinical Trial Update: A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 study evaluating the immune response to zoster vaccination in rheumatoid arthritis patients receiving tofacitinib or placebo with bac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2018-04-11